A fundamental challenge in the care of patients with recurrent high-grade gliomas is the selection of appropriate salvage therapies to control further disease progression. To address this challenge, we have developed a biology-based mathematical model of tumor growth and response initialized and calibrated from patient-specific MRI data to predict which patients will respond to anti-angiogenic therapy. We evaluated the predictive accuracy of this image-driven modeling framework in an initial cohort of four patients. The model accurately predicted future total tumor cell number with an average error of 15%.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords